一、ALIVETECHNOLOGIESPTYLTD投资情况:ALIVETECHNOLOGIESPTYLTD目前是网卓软件开发(上海)有限公司直接控股股东,持股比例为100%;目前ALIVETECHNOLOGIESPTYLTD投资网卓软件开发(上海)有限公司最终收益股份为100%;二、ALIVETECHNOLOGIESPTYLTD的商业合作伙伴:基于公开数据展示,ALIVETECHNOLOGIESPTYLTD与DAVIDCHARLESDANIEL为商业合作伙伴...
Daicel Chiral Technologies (China) CO., LTD. Dara Pharmaceutical Equipment Datwyler DEKON-BUAA(SHANGHAI)INDUSTRIAI CO.,LTD DKSH China Dockweiler AG Everloy (Shanghai) Co.,Ltd. FILTROX AG Freudenberg FST GmbH Gerresheimer China GOOD MO...
BIOWISH Technologies,Inc.-Blue Ash,USA 可速必宁 枯草芽孢杆菌 饲料添加剂 可尔必思美国有限责任公司 Calpis America Inc.,USA 艾特脱 混合型饲料添加剂矿物元素 混合型饲料添加剂 美国艾特维特有限责任公司 Artevet LLC, 1000 N. West S...
Herceptin (trastuzumab) Herceptin BLA 103792 SPOT-LIGHT HER2 CISH Kit P050040S001-S003 Life Technologies, Inc. (trastuzumab) The SPOT-Light HER2 CISH Kit is intended to quantitatively determine HER2 gene amplification in formalin-fixed, paraffin-embedded (FFPE) breast carcinoma tissue sections using ...
57 FIVE D PROPERTY MANAGEMENT (NSW) PTY LTD 子公司 58 Advanced Technologies Group, Inc. 子公司 59 HFF InvestCo LLC 子公司 60 LaSalle Partners, S. de R. L. de C. V. 子公司 61 JLL 2002 子公司 62 Jones Lang LaSalle Belgium Holdings, LLC 子公司 63 Jones Lang LaSalle, S. de R....
申请人: 方舟科技私人有限公司;ARKTECHNOLOGIESPTY.LTD. 办理/代理机构: 北京金杜知识产权代理有限公司 商标进度 注册申请 2021-07-15 初审公告 2021-10-27 已注册 2022-01-28 终止 2032-01-27 商标信息 商标图案 商标名称 CETTIRE 国际分类 第31类-饲料种籽 商标状态 商标注册申请 申请/注册号 57741565...
SPR is a powerful tool for investigating biomolecular interactions with label-free real-time analytical technologies. This effect greatly influences the efficiency, the structure and operation of the sensor, i.e., much greater control of optical properties, sensitivity and selectivity may...
多核苷酸也包括含有包括如本领域中通常实施的非典型核苷酸或经化学修饰核苷酸的多 个核苷酸的分子;参见例如技术手册“RNA Interference (RNAi) and DsiRNAs”,2011 (Integrated DNA Technologies Coralville, ΙΑ)中公开的化学修饰。通常,如本文所述的 多核苷酸(无论是DNA还是RNA或两者以及无论是单链还是双链)都包括...
2008 Prism Payment Technologies (Pty) Ltd. All rights Reserved. Document Number: PR-D2-0792 Version: 01 Issue Date: October 2008 CONFIDENTIALITY: Use of this document is restricted to authorized members or staff of PRISM and to third parties who are authorised by PRISM in terms of written ...